T

Timothy Back

Science Applications International Corporation (United States)

6 papers and 752 citations.

6Publications

752Total Citations

Top publicationsby citations

Administration of Interleukin 12 With Pulse Interleukin 2 and the Rapid and Complete Eradication of Murine Renal Carcinoma

Jon M. Wigginton, Robert H. Wiltrout, Michael J. Brunda et al.|JNCI Journal of the National Cancer Institute|1996

Cited by 160

IL-27 Mediates Complete Regression of Orthotopic Primary and Metastatic Murine Neuroblastoma Tumors: Role for CD8+ T Cells

Rosalba Salcedo, Jon M. Wigginton, Jimmy K. Stauffer et al.|The Journal of Immunology|2004

Cited by 160

IFN-γ and Fas/FasL are required for the antitumor and antiangiogenic effects of IL-12/pulse IL-2 therapy

Jon M. Wigginton, Robert H. Wiltrout, Eilene Gruys et al.|Journal of Clinical Investigation|2001

Cited by 126

IFN-γ and Fas/FasL are required for the antitumor and antiangiogenic effects of IL-12/pulse IL-2 therapy

Jon M. Wigginton, Robert H. Wiltrout, Eilene Gruys et al.|Journal of Clinical Investigation|2001

Cited by 109

Immunologic and Therapeutic Synergy of IL-27 and IL-2: Enhancement of T Cell Sensitization, Tumor-Specific CTL Reactivity and Complete Regression of Disseminated Neuroblastoma Metastases in the Liver and Bone Marrow

Rosalba Salcedo, Jon M. Wigginton, Julie A. Hixon et al.|The Journal of Immunology|2009

Cited by 99

Indexing the rest of 6 publications…